Main navigation

Products we regulate
Product safety
How we regulate
Guidance and resources
News and Community
About us

Mayne Pharma International Pty Ltd

Regulatory activities for this sponsor.

Loading...

ARTG (1) ARTG (1)
Cancellation by sponsor (1) Cancellation by sponsor (1)
Prescription medicine registration (1)

2024 (3) (-) 2024 (3)
2023 (14) 2023 (14)
2022 (11) 2022 (11)
2021 (5) 2021 (5)
2020 (9) 2020 (9)
2019 (4) 2019 (4)
2018 (13) 2018 (13)
2017 (7) 2017 (7)
2015 (2) 2015 (2)
2014 (3) 2014 (3)
2013 (3) 2013 (3)
2012 (4) 2012 (4)
2010 (1) 2010 (1)
2009 (1) 2009 (1)
2007 (1) 2007 (1)
2004 (2) 2004 (2)
2002 (1) 2002 (1)
1999 (1) 1999 (1)
1998 (1) 1998 (1)
1996 (6) 1996 (6)
1994 (3) 1994 (3)
1991 (10) 1991 (10)

Search

Filters applied:

2024

Clear all

Sponsor content

3 result(s) found, displaying 1 to 3

PARECOXIB MYX parecoxib (as sodium) 40 mg powder for injection vial Cancelled under Section 30(1)(c) of the Act

3 October 2024

Cancellation by sponsor

Requested by Mayne Pharma International Pty Ltd
MAYNE PHARMA 5FU fluorouracil 5% w/w cream tube (394830)

6 March 2024

ARTG

Australian Register of Therapeutic Goods (ARTG) information for MAYNE PHARMA 5FU fluorouracil 5% w/w cream tube.
MAYNE PHARMA (Mayne Pharma International Pty Ltd)

10 January 2024

Prescription medicine registration

Active ingredients: fluorouracil.

Is there anything wrong with this page?

Help us improve this page

What were you doing? (mandatory)

What went wrong? (mandatory)

Leave this field blank

Using our website

Accessibility
Privacy
Security
Disclaimer
Copyright
Freedom of information

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control - external site
State and territory contacts

Connect with us

Subscribe to updates
Contact us
Facebook - external site
(formerly Twitter) - external site
Youtube - external site
Instagram - external site
LinkedIn - external site

Help us improve

We are always looking for ways to improve our website.

Provide feedback - external site

The Department of Health and Aged Care acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.

Mayne Pharma International Pty Ltd

Type

Date

PARECOXIB MYX parecoxib (as sodium) 40 mg powder for injection vial Cancelled under Section 30(1)(c) of the Act

MAYNE PHARMA 5FU fluorouracil 5% w/w cream tube (394830)

MAYNE PHARMA (Mayne Pharma International Pty Ltd)

Help us improve this page